OpenEvidence Reportedly Hits $15B Valuation
OpenEvidence is reported to have raised $250M at a $15B valuation, underscoring investor appetite for physician-facing AI search.
Clinical AI search is being priced less like a chatbot category and more like potential healthcare infrastructure.
What happened
OpenEvidence was reported to have raised $250 million at a $15 billion valuation.
The company builds an AI search engine for doctors, helping clinicians retrieve and interpret medical information for patient care. The reported round included major venture backing and hospital-system participation, though the financing had not been directly announced by the company.
The valuation should therefore be treated as reported rather than fully company-confirmed.
Why it matters
Doctors face an overwhelming volume of clinical literature, guidelines and evidence. AI search products can become valuable if they reliably surface relevant information inside a clinician’s workflow without creating new safety or liability problems.
The reported valuation suggests investors believe physician-facing AI tools could become daily infrastructure rather than optional reference products.
The bigger picture
Healthcare AI is moving from ambient documentation and back-office tools toward clinical decision support.
That market is potentially enormous, but adoption depends on trust, medical accuracy, liability management and integration into existing hospital workflows. OpenEvidence’s reported raise shows the scale of investor conviction around that opportunity.